超性心肌病:致病性的机制
Bao Xi Wang1, Yue Ting Zhou1, Yi Pin Zhao2
1Xinxiang Medical University, Xinxiang 453000, Henan, China.
Biomedical and environmental sciences : BES
|September 10, 2025
概括
增高性心肌病 (HCM) 是导致心力衰竭和中风的重要原因. 了解HCM的发病因子对于开发这种广泛的心血管疾病的新疗法至关重要.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 超性心肌病 (HCM) 是心血管疾病 (CVD) 和全球死亡率的主要原因.
- HCM导致心力衰竭 (HF),心房动和中风,通过削弱心脏组织.
- 加强研究正在探索HCM的原因和机制.
研究的目的:
- 审查和综合最新的关于HCM病原学的研究.
- 提供有关HCM背后的机制的见解.
- 确定当前研究的局限性,并建议未来的方向.
主要方法:
- 从关键的体外和体内实验研究中得出的结合结果.
- 对现有的关于HCM病因和病原学的文献进行批判性分析.
- 专家对当前研究和临床管理的观点.
主要成果:
- HCM病原发生涉及复杂的分子和细胞机制.
- 在体外和体外研究揭示了导致心脏功能障碍的关键途径.
- 目前的研究突出了理解和治疗策略的差距.
结论:
- 对HCM病原体的进一步基础研究是必不可少的.
- 提升知识是开发HCM有效疗法的关键.
- 更好的理解将增强对心血管疾病的临床管理和患者结果.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure II: Pathophysiology
752
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
752
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480


